Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
© World Health Organization, 2021. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article..
BACKGROUND: Progress towards elimination of trachoma as a public health problem has been substantial, but the coronavirus disease 2019 (COVID-19) pandemic has disrupted community-based control efforts.
METHODS: We use a susceptible-infected model to estimate the impact of delayed distribution of azithromycin treatment on the prevalence of active trachoma.
RESULTS: We identify three distinct scenarios for geographic districts depending on whether the basic reproduction number and the treatment-associated reproduction number are above or below a value of 1. We find that when the basic reproduction number is <1, no significant delays in disease control will be caused. However, when the basic reproduction number is >1, significant delays can occur. In most districts, 1 y of COVID-related delay can be mitigated by a single extra round of mass drug administration. However, supercritical districts require a new paradigm of infection control because the current strategies will not eliminate disease.
CONCLUSIONS: If the pandemic can motivate judicious, community-specific implementation of control strategies, global elimination of trachoma as a public health problem could be accelerated.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:115 |
---|---|
Enthalten in: |
Transactions of the Royal Society of Tropical Medicine and Hygiene - 115(2021), 3 vom: 06. März, Seite 222-228 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blumberg, Seth [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 18.03.2021 Date Revised 26.07.2022 published: Print UpdateOf: medRxiv. 2020 Oct 27;:. - PMID 33140063 Citation Status MEDLINE |
---|
doi: |
10.1093/trstmh/traa170 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320123154 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320123154 | ||
003 | DE-627 | ||
005 | 20231225172916.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/trstmh/traa170 |2 doi | |
028 | 5 | 2 | |a pubmed24n1067.xml |
035 | |a (DE-627)NLM320123154 | ||
035 | |a (NLM)33449114 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blumberg, Seth |e verfasserin |4 aut | |
245 | 1 | 0 | |a Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2021 | ||
500 | |a Date Revised 26.07.2022 | ||
500 | |a published: Print | ||
500 | |a UpdateOf: medRxiv. 2020 Oct 27;:. - PMID 33140063 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © World Health Organization, 2021. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article. | ||
520 | |a BACKGROUND: Progress towards elimination of trachoma as a public health problem has been substantial, but the coronavirus disease 2019 (COVID-19) pandemic has disrupted community-based control efforts | ||
520 | |a METHODS: We use a susceptible-infected model to estimate the impact of delayed distribution of azithromycin treatment on the prevalence of active trachoma | ||
520 | |a RESULTS: We identify three distinct scenarios for geographic districts depending on whether the basic reproduction number and the treatment-associated reproduction number are above or below a value of 1. We find that when the basic reproduction number is <1, no significant delays in disease control will be caused. However, when the basic reproduction number is >1, significant delays can occur. In most districts, 1 y of COVID-related delay can be mitigated by a single extra round of mass drug administration. However, supercritical districts require a new paradigm of infection control because the current strategies will not eliminate disease | ||
520 | |a CONCLUSIONS: If the pandemic can motivate judicious, community-specific implementation of control strategies, global elimination of trachoma as a public health problem could be accelerated | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a control | |
650 | 4 | |a elimination | |
650 | 4 | |a mass drug administration | |
650 | 4 | |a mathematical modelling | |
650 | 4 | |a trachoma | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Azithromycin |2 NLM | |
650 | 7 | |a 83905-01-5 |2 NLM | |
700 | 1 | |a Borlase, Anna |e verfasserin |4 aut | |
700 | 1 | |a Prada, Joaquin M |e verfasserin |4 aut | |
700 | 1 | |a Solomon, Anthony W |e verfasserin |4 aut | |
700 | 1 | |a Emerson, Paul |e verfasserin |4 aut | |
700 | 1 | |a Hooper, Pamela J |e verfasserin |4 aut | |
700 | 1 | |a Deiner, Michael S |e verfasserin |4 aut | |
700 | 1 | |a Amoah, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Hollingsworth, T Déirdre |e verfasserin |4 aut | |
700 | 1 | |a Porco, Travis C |e verfasserin |4 aut | |
700 | 1 | |a Lietman, Thomas M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transactions of the Royal Society of Tropical Medicine and Hygiene |d 1945 |g 115(2021), 3 vom: 06. März, Seite 222-228 |w (DE-627)NLM000035653 |x 1878-3503 |7 nnns |
773 | 1 | 8 | |g volume:115 |g year:2021 |g number:3 |g day:06 |g month:03 |g pages:222-228 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/trstmh/traa170 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 115 |j 2021 |e 3 |b 06 |c 03 |h 222-228 |